Search

Your search keyword '"Marits, Per"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Marits, Per" Remove constraint Author: "Marits, Per" Database Academic Search Index Remove constraint Database: Academic Search Index
26 results on '"Marits, Per"'

Search Results

1. Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment.

2. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.

Catalog

Books, media, physical & digital resources

3. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay.

4. Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis.

5. Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies.

6. FOXP3 and survival in urinary bladder cancer.

7. Detection of Immune Responses Against Urinary Bladder Cancer in Sentinel Lymph Nodes

8. The many flavors of tumor-associated B cells.

12. Feasibility of T-Cell-Based Adoptive Immunotherapy in the First 12 Patients with Advanced Urothelial Urinary Bladder Cancer. Preliminary Data on a New Immunologic Treatment Based on the Sentinel Node Concept

13. FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans.

14. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.

15. Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.

16. Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.

17. Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer.

19. Predictive immunomonitoring — The COST ENTIRE initiative.

20. Profiling of CD4+ T Cells with Epigenetic Immune Lineage Analysis.

21. A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2.

22. Tumour‐associated B cells in urothelial urinary bladder cancer.

23. CCR2 upregulated on peripheral T cells in osteoarthritis but not in bone marrow.

24. Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.

25. Comment on "Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies".

26. CCR9-expressing CD14+HLA-DRhi blood monocytes promote intestinal inflammation in IBD.